SANOFI INDIA LTD - Announcement under Regulation 30 (LODR)-Change in Directorate

Sanofi India Ltd - Announcement under Regulation 30 (LODR)-Change in Directorate

Download	< Back
03 Nov 2022
Pursuant to the requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the the Board of Directors at its meeting held today i.e., 3rd November 2022 noted the resignation of Mr. Charles Billard and based on the recommendation of the Nomination and Remuneration Committee, approved the appointment of Ms. Annapurna Das (DlN: 08634664) as an Additional and Non-Executive (Non-Independent) Director of the Company with effect from 3rd November 2022. The said appointment will be subject to the approval of the Members of the Company through Postal Ballot.
View all announcements for Sanofi India Ltd	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us